Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Stolley, Melinda R

Medical College Of Wisconsin
United States

Every Day Counts: A lifestyle program for women metastatic breast cancer 5R01CA258759-05 PAR-18-893 (R01 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Song, Ming

University Of Louisville
United States

Dietary fructose and NASH/HCC progression 5R21CA290420-02 Amit Kumar, Ph.D.
Zi, Xiaolin

University Of California-Irvine
United States

Nautral products for targeting Skp2 in cancer interception 5UG3CA290368-02 Altaf Mohammed, Ph.D.
Miyano, Masaru

Beckman Research Institute/City Of Hope
United States

Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials 1R03CA300614-01 Sidney Fu, M.D.
Huang, Ying

Western University Of Health Sciences
United States

Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol 5R01CA269653-04 Anda Vlad, M.D., Ph.D.
Li, Christopher I

Fred Hutchinson Cancer Center
United States

Fred Hutchinson Breast Cancer Clinical Validation Center 5U01CA152637-15 Sidney Fu, M.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-09 Matthew Young, Ph.D.
Clapper, Margie L.

Research Inst Of Fox Chase Can Ctr
United States

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center 5U54CA272686-04 John Clifford, Ph.D.
Cocucci, Emanuele

Ohio State University
United States

A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL 5R01CA270251-04 PAR-20-053 (R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Demb, Joshua Brian

University Of California, San Diego
United States

Optimal early colorectal cancer screening initiation 5R00CA267181-04 Claire Zhu, Ph.D.